Allen Nissenson

CIK 1441889 · Chief Medical Officer · last filed 2025-05-21

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$1.96M

Companies

4

Total Filings

31

Lifetime Open-Market Net

-$2.78M

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
RMTI Director 142,597 $0.62 $89.1K $0 7 2025-05-21
ELTX Director $14.85 $0 3 2025-05-20
Elicio Therapeutics, Inc. (ANGN) Delisted Director 9,383 $10.00 $93.8K $10.9K 3 2022-06-13
DVA Chief Medical Officer 8,990 $208.66 $1.88M -$2.79M 18 2014-02-18

Recent Filings · Page 3 of 4

31 filings
Form 4 transactions across all companies, newest first.
Filed Symbol Action Net Shares Net $ Link
2012-11-16 DVA Mixed -$462.4K EDGAR
2012-08-08 DVA Mixed -$387.8K EDGAR
2012-05-25 DVA Mixed -$481.4K EDGAR
2011-05-19 DVA Mixed -$216.9K EDGAR
2011-04-15 DVA Grant (A) $0 EDGAR
2011-03-01 DVA Mixed -$86.6K EDGAR
2010-11-12 DVA Mixed -$131.9K EDGAR
2010-06-21 DVA Mixed -$12.6K EDGAR
2010-03-16 DVA Mixed -$262.7K EDGAR
2009-03-04 DVA Grant (A) $0 EDGAR
Showing 2130 of 31
Page 3 of 4
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.